ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. C. 医薬保健学域; 医学類・薬学類・医薬科学類・保健学類
  2. c 10. 学術雑誌掲載論文(医・保健)
  3. 1. 査読済論文(医学・保健)

Current understanding and management of nasopharyngeal carcinoma

http://hdl.handle.net/2297/27788
http://hdl.handle.net/2297/27788
0ce9c8a2-481e-4f86-b305-4969648edfc6
名前 / ファイル ライセンス アクション
ME-PR-YOSHIZAKI-T-137.pdf ME-PR-YOSHIZAKI-T-137.pdf (123.2 kB)
Item type 会議発表論文 / Conference Paper(1)
公開日 2017-10-03
タイトル
タイトル Current understanding and management of nasopharyngeal carcinoma
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_5794
資源タイプ conference paper
著者 Yoshizaki, Tomokazu

× Yoshizaki, Tomokazu

WEKO 79
e-Rad 70262582
金沢大学研究者情報 70262582
研究者番号 70262582

Yoshizaki, Tomokazu

Search repository
Ito, Makoto

× Ito, Makoto

WEKO 21450
研究者番号 50283106

Ito, Makoto

Search repository
Murono, Shigeyuki

× Murono, Shigeyuki

WEKO 20582
e-Rad 20345622
研究者番号 20345622

Murono, Shigeyuki

Search repository
Wakisaka, Naohiro

× Wakisaka, Naohiro

WEKO 20177
e-Rad 70377414
金沢大学研究者情報 70377414
研究者番号 70377414

Wakisaka, Naohiro

Search repository
Kondo, Satoru

× Kondo, Satoru

WEKO 21455
金沢大学研究者情報 70436822
研究者番号 70436822

Kondo, Satoru

Search repository
Endo, Kazuhira

× Endo, Kazuhira

WEKO 22167
金沢大学研究者情報 30547154
研究者番号 30547154

Endo, Kazuhira

Search repository
提供者所属
内容記述タイプ Other
内容記述 金沢大学医薬保健研究域医学系
書誌情報 Auris Nasus Larynx

巻 39, 号 2, p. 137-144, 発行日 2012-04-30
ISSN
収録物識別子タイプ ISSN
収録物識別子 0385-8146
NCID
収録物識別子タイプ NCID
収録物識別子 AA00061157
DOI
関連タイプ isVersionOf
識別子タイプ DOI
関連識別子 10.1016/j.anl.2011.02.012
出版者
出版者 Elsevier
抄録
内容記述タイプ Abstract
内容記述 Nasopharyngeal carcinoma (NPC) is a kind of rare head and neck cancer in Japan. However, NPC has some unique features. It is one of the most popular cancers in southern China, Southeast Asia, the Arctic, and the middle East/north Africa. This distinctive racial, ethnical, and geographic predisposition to NPC implies that both genetic susceptibility and environmental factors contribute to the development of this tumor. NPC is an Epstein-Barr virus - associated tumor. Consistent elevation of EBV antibody titers is a well-established risk factor of development of NPC. Not only pathophysiological relationship, but also molecular mechanism of EBV-mediated carcinogenesis has been enthusiastically investigated. LMP1, an EBV primary oncogene, upregulates each step of metastasis, and contribute to highly metastatic feature of NPC. A tumor suppressor gene p53 is mostly intact and overexpressed in NPC whereas expression of p16, a cyclin-dependent kinase inhibitory protein, is downregulated in 2/3 of NPC. Intention modulated radiotherapy (IMRT) is now getting prevalent for the treatment of NPC because of complicated structure and location of nasopharynx. A good therapeutic result can be achieved by distributing a high dose to the tumor while keeping down normal tissue complications by reducing radiation dose to normal tissues. Chemotherapy is important to control distant metastasis of chemoradiosensitive NPC, and thus, should play an important role. However, most effective combination of anti-tumor drugs, protocol of chemoradiotherapy has not well-established. Finally, molecular targeting therapy, including targeting EBV gene product, has been developing and on the way to the clinical use. © 2011 Elsevier Ireland Ltd. All rights reserved.
著者版フラグ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
関連URI
識別子タイプ URI
関連識別子 http://www.elsevier.com/locate/issn/03858146
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-28 01:04:24.175152
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3